Ectopic ACTH syndrome
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Ectopic adrenocorticotropic secretion (EAS) is responsible for 12-17% of cases of Cushing's syndrome (CS) and covers a range of tumours, from undetectable benign lesions to widespread metastases. The syndrome is often associated with severe hypercortisolaemia, which aggravates the underlying condition. EAS requires a complete workup that includes the establishment of endogenous CS, diagnosis of adrenocorticotropic hormone (ACTH) dependency, localization of the source of ACTH secretion and rapid biochemical control of hypercortisolaemia. Dynamic endocrine tests should include inferior petrosal sinus sampling with CRH stimulation. Localization studies depend on the availability of reliable high-resolution cross-sectional imaging. This systematic review of the largest published series of patients with EAS (over 380 patients) reveals the common trends in the prevalence and management of this syndrome. The concept of 'occult' EAS has been revisited and the terms 'overt' and 'covert' EAS introduced. In addition to small cell lung carcinoma, the most common causes of ectopic EAS are bronchial carcinoids, thymic tumours, islet cell tumour of the pancreas, medullary thyroid carcinomas, and phaeochromocytomas. Their prevalence and the best localization modalities are presented. Medical and surgical management is discussed on the basis of the extensive experience of major referral centres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
A physiologic approach to diagnosis of the Cushing syndrome.
Raff, H., & Findling, J. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00010 · Cited by 186 · cited 2×
“As correction of cortisol hypersecretion by the selective removal of a pituitary microadenoma or of a solitary bronchial carcinoid tumour has a high probability of resolving the condition, it is essential to distinguish EAS from the much more common Cushing’s disease (CD) and, in the former, to make every effort to lo…”
BackgroundDiagnosis and differential diagnosis of Cushing’s syndrome
Findling, J. W., & Raff, H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70209-7 · Cited by 147 · cited 6×
“%) following the HDDST (4,19).”
BackgroundMethodInfluential
Research works printed but not linked: 49
- Brown WH, 1928, A case of pluriglandular syndrome: Diabetes of bearded women, Lancet, 2, 1022, 10.1016/S0140-6736(00)84800-X · doi:10.1016/s0140-6736(00)84800-x
- Liddle GW, 1969, Clinical and laboratory studies of ectopic humoral syndromes, Recent Prog Horm Res, 25, 283
- Isidori AM, 2003, Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 88, 5299, 10.1210/jc.2003-030510 · DOI · Paper page
- Kaltsas GA, 1999, A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome, J Clin Endocrinol Metab, 84, 487
- Baylin SB, 1980, Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications, Endocr Rev, 1, 45, 10.1210/edrv-1-1-45 · DOI · Paper page
- Wajchenberg BL, 1994, Ectopic adrenocorticotropic hormone syndrome, Endocr Rev, 15, 752, 10.1210/edrv-15-6-752 · DOI · Paper page
- Isidori AM, 2006, The Ectopic Adrenocorticotropin Syndrome: clinical features, diagnosis, managment and long-term follow-up, J Clin Endocrinol Metab, 91, 371, 10.1210/jc.2005-1542 · DOI · Paper page
- Isidori AM, 2006, Ectopic ACTH syndrome, Front Horm Res, 35, 143, 10.1159/000094323 · DOI
- Ilias I, 2005, Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health, J Clin Endocrinol Metab, 90, 4955, 10.1210/jc.2004-2527 · DOI · Paper page
- Doppman JL, 1989, Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients, Radiology, 172, 115, 10.1148/radiology.172.1.2544919 · DOI · Paper page
- Findling JW, 1986, Occult ectopic secretion of corticotropin, Arch Intern Med, 146, 929, 10.1001/archinte.1986.00360170151022 · doi:10.1001/archinte.1986.00360170151022
- Howlett TA, 1986, Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production, Clin Endocrinol, 24, 699, 10.1111/j.1365-2265.1986.tb01667.x · DOI · Paper page
- Imura H, 1975, Studies on ectopic ACTH-producing tumors: II. Clinical and biochemical features of 30 cases, Cancer, 35, 1430, 10.1002/1097-0142(197505)35:5<1430::AID-CNCR2820350529>3.0.CO;2-O · doi:10.1002/1097-0142(197505)35:5<1430::aid-cncr2820350529>3.0.co;2-o
- Aniszewski JP, 2001, Cushing syndrome due to ectopic adrenocorticotropic hormone secretion, World J Surg, 25, 934, 10.1007/s00268-001-0032-5 · DOI · Paper page
- Salgado LR, 2006, Ectopic ACTH syndrome: our experience with 25 cases, Eur J Endocrinol, 155, 725, 10.1530/eje.1.02278 · DOI · Paper page
- Hernandez I, 2006, Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor, Arch Med Res, 37, 976, 10.1016/j.arcmed.2006.05.015 · DOI
- Beuschlein F, 2002, Ectopic pro-opiomelanocortin syndrome, Endocrinol Metab Clin North Am, 31, 191, 10.1016/S0889-8529(01)00025-1 · DOI
- Limper AH, 1992, The Cushing syndrome induced by bronchial carcinoid tumors, Ann Intern Med, 117, 209, 10.7326/0003-4819-117-3-209 · DOI
- Shepherd FA, 1992, Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer, J Clin Oncol, 10, 21, 10.1200/JCO.1992.10.1.21 · DOI
- Orth DN, 1995, Cushing's syndrome, N Engl J Med, 332, 791, 10.1056/NEJM199503233321207 · DOI · Paper page
- Delisle L, 1993, Ectopic corticotropin syndrome and small-cell carcinoma of the lung: Clinical features, outcome, and complications, Arch Intern Med, 153, 746, 10.1001/archinte.1993.00410060054009 · doi:10.1001/archinte.1993.00410060054009
- Sarlis NJ, 2000, Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin, J Clin Endocrinol Metab, 85, 42
- Putignano P, 2000, Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment, J Clin Endocrinol Metab, 85, 3309
- Van Sickle DG, 1972, Carcinoid tumors: Analysis of 61 cases, including 11 cases of carcinoid syndrome, Cleve Clin Q, 39, 79, 10.3949/ccjm.39.2.79 · doi:10.3949/ccjm.39.2.79
- Newell-Price J, 1999, Diagnosis and management of Cushing's syndrome, Lancet, 353, 2087, 10.1016/S0140-6736(99)99091-8 · DOI
- Kaye TB, 1990, The Cushing syndrome: an update on diagnostic tests, Ann Intern Med, 112, 434, 10.7326/0003-4819-76-3-112-6-434 · DOI · Paper page
- Nieman LK, 1993, A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 77, 1308
- Newell-Price J, 2002, Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome, J Clin Endocrinol Metab, 87, 1640
- Reimondo G, 2003, The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome, Clin Endocrinol, 58, 718, 10.1046/j.1365-2265.2003.01776.x · DOI · Paper page
- Aron DC, 1997, Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 82, 1780
- Nieman LK, 1986, The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome, Ann Intern Med, 105, 862, 10.7326/0003-4819-105-6-862 · DOI · Paper page
- Swearingen B, 2004, Diagnostic errors after inferior petrosal sinus sampling, J Clin Endocrinol Metab, 89, 3752, 10.1210/jc.2003-032249 · DOI · Paper page
- Zarrilli L, 1995, Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome, World J Surg, 19, 150, 10.1007/BF00317003 · DOI
- McNally PG, 1993, Preliminary observations using endocrine markers of pituitary venous dilution during bilateral simultaneous inferior petrosal sinus catheterization in Cushing's syndrome: is combined CRF and TRH stimulation of value?, Clin Endocrinol, 39, 681, 10.1111/j.1365-2265.1993.tb02427.x · DOI · Paper page
- Bonelli FS, 2000, Adrenocorticotropic hormone-dependent Cushing's syndrome: sensitivity and specificity of inferior petrosal sinus sampling, AJNR Am J Neuroradiol, 21, 690
- Colao A, 2001, Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study, Eur J Endocrinol, 144, 499, 10.1530/eje.0.1440499 · DOI · Paper page
- Shrager JB, 1997, Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: a more aggressive variant of typical carcinoid, J Thorac Cardiovasc Surg, 114, 367, 10.1016/S0022-5223(97)70182-X · doi:10.1016/s0022-5223(97)70182-x
- Torpy DJ, 1999, Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients, J Clin Endocrinol Metab, 84, 1186, 10.1210/jcem.84.4.5576 · DOI
- De Herder WW, 1999, Octapeptide somatostatin-analogue therapy of Cushing's syndrome, Postgrad Med J, 75, 65, 10.1136/pgmj.75.880.65 · DOI
- Tabarin A, 1999, Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome, J Clin Endocrinol Metab, 84, 1193, 10.1210/jcem.84.4.5583 · DOI
- Tsagarakis S, 2003, A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome, J Clin Endocrinol Metab, 88, 4754, 10.1210/jc.2003-030525 · DOI · Paper page
- Fanti S, 2003, Somatostatin receptor scintigraphy for bronchial carcinoid follow-up, Clin Nucl Med, 28, 548, 10.1097/00003072-200307000-00003 · doi:10.1097/00003072-200307000-00003
- Pacak K, 2004, The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome, J Clin Endocrinol Metab, 89, 2214, 10.1210/jc.2003-031812 · DOI · Paper page
- Doppman JL, 1992, Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling, Radiology, 184, 71, 10.1148/radiology.184.1.1319078 · DOI
- Hearn PR, 1988, Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin), Clin Endocrinol, 28, 181, 10.1111/j.1365-2265.1988.tb03654.x · doi:10.1111/j.1365-2265.1988.tb03654.x
- Pivonello R, 2005, Cabergoline plus lanreotide for ectopic Cushing's syndrome, N Engl J Med, 352, 2457, 10.1056/NEJM200506093522322 · DOI · Paper page
- Drake WM, 1998, Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis, J Clin Endocrinol Metab, 83, 3542
- Krakoff J, 2001, Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome, J Clin Endocrinol Metab, 86, 4104
- Greening JE, 2005, Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease, Horm Res, 64, 140
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Cushing’s syndrome: from physiological principles to diagnosis and clinical care
Raff, H., & Carroll, T. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282871 · Cited by 137
Ceccato, F., Barbot, M., Zilio, M., Ferasin, S., Occhi, G., Daniele, A., Mazzocut, S., Iacobone, M., Betterle, C., Mantero, F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0159 · Cited by 75
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa107 · Cited by 36
“Neoplastic hypercortisolism is often responsible for cardiometabolic problems, including obesity, diabetes, hypertension, and low bone density, as well as significant neurocognitive and neuropsychiatric challenges [1-16].”
Background
Metadata
- Authors
- Isidori, A. M., & Lenzi, A.
- Venue
- Arquivos Brasileiros de Endocrinologia & Metabologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2007-11
- Volume
- 51
- Issue
- 8
- Pages
- 1217-1225
- ISSN
- 0004-2730 (ISSN-L)
- OpenAlex
- W2127912481
- Cited by
- 174
- References
- 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ectopic ACTH syndrome. https://app.cochat.ai/papers/10.1590/s0004-27302007000800007
- The paper
- Isidori, A. M., & Lenzi, A. (2007). Ectopic ACTH syndrome. Arquivos Brasileiros de Endocrinologia & Metabologia. https://doi.org/10.1590/s0004-27302007000800007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.